Pentagon to Begin Annual Testosterone Testing for Service Members Over 30

The Pentagon will implement annual testosterone deficiency testing for service members aged 30 and older, as announced by Defense Secretary Pete Hegseth on Tuesday. This new screening will be integrated into the Defense Department's periodic health assessment, which has been mandatory since 2016 and evaluates medical, behavioral, and mental health, as well as deployment readiness. Service members recommended for treatment will have the option to receive testosterone replacement therapy, while those under 30 may volunteer for testing. Hegseth characterized the initiative as a means to restore and optimize natural capabilities, emphasizing the commitment to providing high-quality medical care to military personnel. According to the Mayo Clinic, testosterone levels in males typically decline by about 1% per year after the age of 30 or 40. The U.S. Food and Drug Administration does not approve testosterone replacement therapy for males without specific forms of hypogonadism. The Defense Department has not provided additional comments regarding the initiative or the FDA's guidance on testosterone therapy.